Zhihao Wu

Title: Zhihao Wu: Innovator in Cancer Treatment

Introduction

Zhihao Wu is a prominent inventor based in New York, NY, specializing in the development of innovative therapies for cancer treatment. With a total of two patents to his name, he has made significant contributions to the field of immunology.

Latest Patents

His latest patents include "Anti-polysialic acid antibodies and uses thereof," which focuses on immunoglobulin-related compositions that can bind to and neutralize the activity of polysialic acid. These antibodies are particularly useful in methods for detecting and treating polysialic acid-associated cancers. Another notable patent is "A33 antibody compositions and methods of using the same in radioimmunotherapy," which involves antibodies that can bind to and neutralize the activity of the A33 protein, aiding in the detection and treatment of A33-positive cancers.

Career Highlights

Zhihao Wu is affiliated with the Memorial Sloan Kettering Cancer Center, where he continues to advance research in cancer therapies. His work is characterized by a commitment to improving patient outcomes through innovative medical solutions.

Collaborations

He collaborates with esteemed colleagues such as Nai-Kong V Cheung and Hong Xu, contributing to a dynamic research environment focused on cancer treatment advancements.

Conclusion

Zhihao Wu's contributions to cancer research through his patents and collaborations highlight his role as an influential inventor in the medical field. His work continues to pave the way for new therapeutic approaches in oncology.